Biodesix (BDSX) Net Cash Flow Growth (3y) (2022 - 2026)
Biodesix (BDSX) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 89.23% |
| 10 | Biodesix | 208.57 Mn | 183.00 Mn | 21.35 Mn | 33.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.32% |
| Dec 31, 2025 | -55.97% |
| Sep 30, 2025 | 32.50% |
| Jun 30, 2025 | -36.41% |
| Mar 31, 2025 | 19.04% |
| Dec 31, 2024 | 30.24% |
| Sep 30, 2024 | -8.63% |
| Jun 30, 2024 | 211.16% |
| Mar 31, 2024 | -29.00% |
| Dec 31, 2023 | -51.30% |
| Sep 30, 2023 | 34.93% |
| Jun 30, 2023 | -53.35% |
| Mar 31, 2023 | -140.71% |
| Dec 31, 2022 | 112.64% |